4//SEC Filing
McCauley Thomas 4
Accession 0000950170-24-013378
CIK 0001850838other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:14 PM ET
Size
7.8 KB
Accession
0000950170-24-013378
Insider Transaction Report
Form 4
McCauley Thomas
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-07+125,000→ 125,000 totalExercise: $3.59Exp: 2034-02-06→ Common Stock (125,000 underlying) - Award
Stock Option (Right to Buy)
2024-02-07+75,000→ 75,000 totalExercise: $3.59Exp: 2034-02-06→ Common Stock (75,000 underlying)
Footnotes (2)
- [F1]The option vests and becomes exercisable with respect to 25% of the underlying shares on February 7, 2025 and in twelve (12) equal quarterly installments thereafter such that the option will become fully vested and exercisable on February 7, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
- [F2]The option vests and becomes exercisable in three equal installments on each of October 7, 2024, June 7, 2025 and February 7, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
Documents
Issuer
Omega Therapeutics, Inc.
CIK 0001850838
Entity typeother
Related Parties
1- filerCIK 0001858760
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 5:14 PM ET
- Size
- 7.8 KB